NCT04340752View on ClinicalTrials.gov

Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions

Rotator Cuff Tears

Interventions

DRUG

Indocyanine Green

ICG is an injectable fluorescent pigment that binds to proteins in the blood and allows surgery teams to view blood vessels with greater precision. The ICG will not affect the course of the operative or postoperative period, and will be injected intravenously prior to the actual repair

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT04340752 - Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy | Biotech Hunter | Biotech Hunter